Janine North is a seasoned clinical research professional with over two decades of experience leading Phase 1–4 global clinical trials across therapeutic areas including oncology, neuroscience, endocrinology, and immunology. As Director of Clinical Operations at Usona Institute, Janine provides strategic and operational oversight of the Phase 3 clinical program in patients with major depressive disorder, ensuring adherence to regulatory standards, timelines, and budget objectives.
Prior to joining Usona, Janine held executive roles at TerSera Therapeutics and PilotPay Incorporated, where she managed clinical development teams and helped drive operational innovation. At AbbVie, Abbott Labs and TAP Pharmaceuticals, she was instrumental in executing complex global trials and supporting regulatory submissions for multiple drug and device programs.
Known for her leadership in clinical quality, CRO/vendor management, and process improvement, Janine is passionate about building high-performing teams and advancing research that makes a meaningful impact. She holds a Bachelor of Science in Molecular Biology from The Evergreen State College.